Genturi Inc. is a genomics startup organized around development of integrated platforms for the rapid delivery of low-cost, high-resolution genomic maps for clinical and non-clinical research and diagnostics. With strong ties by leading personnel to University of North Caroina Chapel Hill, Genturi's platforms are designed to change the study of all forms of structural variants, providing low-cost and high-speed access to this presently difficult to acquire genomic information. The ease of accessibility to structural will accelerate the corresponding associations with disease states and clinical adoption. With powerful purpose-built platforms, Genturiâs initial focus is on research markets, with clinical applications following later.
